Document:

Termination Agreement with Felix Marx

			
	

	 	Exhibit 10.37

 Identive Group 1900
Carnegie Ave., Bldg. B Santa Ana, CA 92705 USA 
 December 7, 2010 
 Mr. Felix Marx 
 Inge-Morath-Strasse 42h, 

8045 Graz-Andritz, 
 Austria 

Dear Felix: 
 Pursuant to
paragraph 4(b) of the Employment Agreement, dated as of February 28, 2010, with effect from March 1, 2010, as amended by that certain Amendment to Employment Agreement, dated as of August 23, 2010 (the “Employment
Agreement”), Identive Group, Inc. (the “Company”) and you (“You” or the “Executive”) hereby mutually agree to the termination of such Employment Agreement with effect from December 31, 2010 (the
“Effective Date”). 
 1. Settlement. 
 (a) In consideration for your execution of this Letter Agreement and your compliance with the promises and obligations set forth herein, the Company has agreed to pay You a lump sum of €250,000, less
customary payroll, withholding and other taxes as may be required under German law, on or prior to the Effective Date, in full and final settlement of any and all amounts due to You (i) under the Employment Agreement, including, but not limited
to, paragraph 2, paragraph 3(a) and (d), and paragraph 4, (ii) pursuant to the previously-approved grant to You of 180,000 shares of the Company’s common stock under the 2010 Bonus and Incentive Plan in recognition of your efforts in
connection with the consummation of the acquisition of Bluehill-ID AG, which grant has been heretofore deferred at your request, and (iii) any claimsYou may now have or in the future may have against the Company, its directors, officers,
employees, affiliates or agents. As more specfically provided in paragraph 3 below, You agree to hereby waive and forever relinquish any right or entitlement to any and all amounts to which You may be entitled in connection with the matters set
forth in clauses (i), (ii) and (iii) of the preceding sentence in the absence of this Letter Agreement or otherwise. 

(b) The Company agrees that You are not required to repay, nor will any deduction or offset be made by the Company with respect to, the
Break-up Fee (as defined in the Employment Agreement) previously paid to you pursuant to paragraph 2(d) of the Employment Agreement. 
 (c) For the avoidance of doubt, all benefits to which You are entitled under paragraph 3(b), (c) and (e) of the Employment Agreement will continue until the Effective Date and will terminate
upon the close of business on such date. Any requests by You for reimbursement of business expenses incurred prior to the Effective Date must be received by the Company no later than January 10, 2011 or shall be thereafter be deemed waived.

  

			
	Identive Group	 	T +1 949 250 8888
	1900 Carnegie Ave., Bldg. B	 	F +1 949 250 7263
	Santa Ana, CA 92705	 	info@identive-group.com
	USA	 	www.identive-group.com

  

			
		  	Company  ASA
	BOS 46,694,847v2 12-6-10	  	Executive  FM 

 Felix Marx 
 December 7, 2010 
  Page
 2
 of 5 
  

2. Consulting Agreement. The Company agrees to negotiate in good faith with You mutually agreeable terms and conditions relating to
the provision by You of certain consulting and advisory services to the Company, such services to be performed during 2011 at the rate of €25,000 per month with a minimum term of four (4) months. 

3. Waiver and Release. You, of your own free will, voluntarily waive, release and forever discharge the Company, and all of its
shareholders, officers, directors, insurers, agents and employees, both in their official and individual capacities, and all of the Company’s affiliates, subsidiaries, divisions, predecessors, successors, and assigns (all of whom who are
collectively referred to in this Agreement as the “Released Parties”) of and from any and all actions or causes of action, suits, grievances, claims, benefits, vacation and sick pay, debts, charges, complaints, commissions, bonuses, stock
options or share awards, wages, salary, equity, contracts (whether oral or written, express or implied from any source), and promises whatsoever, in law or equity, which You, or your heirs, executors, administrators, successors and assigns, may
have, or may have knowledge of or may be charged with knowledge of, as of the date of this Letter Agreement for, upon, or by reason of any matter, cause or thing whatsoever including, but not limited to, any and all matters arising out of your
employment by the Company or the cessation of said employment and including, but not limited to, any and all claims You have or may have relating to, or arising out of your employment by the Company, or any claimYou may have for breach of any
agreements, including the Employment Agreement, arising out of or relating to your employment, or that You have been wrongfully terminated by the Company, including any claim for harassment or discrimination, discharge in violation of public policy
and/or violation of any foreign, state and/or federal law, regulation or ordinance and/or public policy, contract, tort, or anything having any bearing whatsoever on your compensation, terms and conditions of employment and or cessation of your
employment with the company which You ever had, now have or may have as of the date of the execution of this Letter Agreement. 

You acknowledge the existence of and, with respect to the releases given in the above paragraph, expressly waive and relinquish any and
all rights and benefits You have or may have under California Civil Code, Section 1542, or any comparable provision under applicable law, which provides: 
 A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS WHICH THE CREDITOR DOES NOT KNOW OR SUSPECT TO EXIST IN HIS OR HER FAVOR AT THE TIME OF EXECUTING THE RELEASE, WHICH IF KNOWN BY HIM OR HER MUST HAVE MATERIALLY
AFFECTED HIS OR HER SETTLEMENT WITH THE DEBTOR. 
 You acknowledge that You are aware that You may hereafter discover facts
different from or in addition to those which You now know or believe to be true with respect to the matters released herein, and agree that the releases so given above shall be and remain in effect as a full and complete release of the respective
claims, notwithstanding any such different or additional facts. 

  

			
	Identive Group	  	Company  ASA
	BOS 46,694,847v2 12-6-10	  	Executive  FM 

 Felix Marx 
 December 7, 2010 
  Page
 3
 of 5 
  

4. Confidentiality. You agree that the existence, terms and conditions of this Letter Agreement are fully confidential and
may not be disclosed by You to any other person or entity except as may be required by law (including in response to regulatory, judicial, administrative, or other governmental inquiry or process), or to an immediate family member, or your
accountant, attorney or personal or financial advisor. You acknowledge and agree that the Company may issue a press release in connection with the severance of your relationship with the Company and You agree to cooperate with the Company in the
preparation and issuance thereof. 
 Nothing herein shall limit your right under applicable law to provide truthful information
to regulatory, judicial, administrative or other governmental authorities, including participation in any investigation or proceeding conducted by federal, state, foreign or local authorities. Notwithstanding the foregoing, You agree to waive your
right to recover monetary damages in any charge, complaint, or lawsuit filed by You or by anyone else on your behalf. Nothing herein shall limit your right to describe to your prospective employer, on a need to know basis, any limitations applicable
to You regarding confidentiality. 
 5. Confidential Information; Non-Competition and Non-Solicitation. You
acknowledge and agreed to be bound by your continuing performance obligations to the Company through the Effect Date as well as your continuing obligations from and after the Effective Date contained under paragraphs 5 and 6 of the Employment
Agreement relating to the treatment of the Company’s confidential information, return of Company property, and non-solicitation. You further agree that for and during the 12-month period beginning on the Effective Date and ending
December 31, 2011, You shall not engage in or participate in any entity in any industry that competes, directly or indirectly, with the businesses of the Company or any of its subsidiaries or affiliates without the prior written consent of the
Company. You agree that the foregoing restrictions are appropriate in duration and scope given your prior positions as a director and executive officer of the Company. You further acknowledge and agree that a breach of the covenants contained in
such paragraphs may not be sufficiently compensable by monetary damages and that therefore the Company party may pursue all available equitable remedies, including injunctive relief. 

6. Entire Agreement. This Letter Agreement contains the sole and entire agreement and understanding between You and the Company
with respect to the entire subject matter hereof. No other agreement, oral or written, shall be deemed to exist with or to bind either of the parties hereto with respect to the entire subject matter hereof. This Letter Agreement supersedes any
previous negotiations, agreements and understandings concerning the subject matter of this Letter Agreement. No provision hereof may be waived other than by a writing signed by both parties hereto. Waiver of any one provision herein shall not be
deemed to be a waiver of any other provision herein. This Letter Agreement may be modified or amended only by a written agreement executed by the parties hereto. 
 7. Successors and Assigns. This Letter Agreement is personal to You and may not be assigned by You. All payments and benefits to be provided to You pursuant to paragraph 1 above shall be made to
your estate in the event of your death prior to the receipt thereof. The Company shall, however, have the absolute, unfettered right to assign this Letter Agreement to a successor-in-

  

			
	Identive Group	  	Company  ASA
	BOS 46,694,847v2 12-6-10	  	Executive  FM 

 Felix Marx 
 December 7, 2010 
  Page
 4
 of 5 
  
 
interest to the Company and it shall inure to the benefit of and shall be binding upon the predecessors, successors and assigns of Company. This Letter Agreement is not intended to constitute a
third-party beneficiary contract. 
 8. Severability. In the event that any of the terms or provisions of this Letter
Agreement are found to be legally unenforceable, then the remaining terms and conditions shall nevertheless be fully enforceable without regard to any such provision or terms that are found to be legally unenforceable. 

9. Independent Counsel/Advisor. The Company has advised You to consult with independent legal counsel, tax consultant or any
advisor of your choosing prior to executing this Letter Agreement. You acknowledge that You have had the opportunity to do so and have consulted with legal counsel and all other counsel or advisors as You have deemed necessary or appropriate. Each
party acknowledges and represents that it or he has entered into this Letter Agreement freely, knowingly and without coercion and based on its or his judgment and not in reliance upon any representation or promise made by any other party. The
parties hereto agree to bear their own costs and attorneys’ fees incurred in connection with this Letter Agreement and the subject matter hereof. 
 10. Governing Law. The terms and provisions of this Agreement shall be construed, interpreted and governed by the laws of the State of Delaware. 

[Remainder of page intentionally left blank.] 

  

			
	Identive Group	  	Company  ASA
	BOS 46,694,847v2 12-6-10	  	Executive  FM 

 Felix Marx 
 December 7, 2010 
  Page
 5
 of 5 
  

This Letter Agreement may be executed in one or more counterparts, each of which shall be deemed an original but each of which, together,
shall be deemed to constitute a single document. 
 Executed as of the date first set forth above. 

 

					
	Identive Group, Inc.
		
	BY:	 	
      /S/    AYMAN S.
ASHOUR

	Name:  Ayman S. Ashour

 Agreed
to this 7th day of December, 2010: 
  

	
	
                /S/ 
   FELIX MARX

	                          Felix
Marx

  

			
	Identive Group	  	Company  ASA
	BOS 46,694,847v2 12-6-10	  	Executive  FMConsulting Agreement, dated as of August 1, 2010

 EXHIBIT 10.28 
 CONSULTING AGREEMENT 
 This Consulting Agreement (this
“Agreement”) is entered into as of August 1, 2010 (the “Effective Date”), by and between EnteroMedics Inc. (the “Company”), a Delaware corporation, whose principal place of business is 2800 Patton Road, St. Paul,
MN 55113, and Nicholas L. Teti, Jr. (the “Consultant”), whose address is 405 Alan Road Santa Barbara, CA, 93109. 

WHEREAS, the Consultant currently serves as a member of the Company’s Board of Directors; 

WHEREAS, the Company desires that the Consultant provide additional services to the Company as an independent contractor and the
Consultant desires to provide such additional services as an independent contractor. 
 NOW, THEREFORE, in consideration of the
mutual representations, promises and agreements contained herein, the adequacy and sufficiency of which are hereby acknowledged, the Company and the Consultant hereby agree as follows: 

1. Term of Agreement. The Company hereby engages the Consultant as a consultant, subject to the terms and conditions hereof, for
the period commencing as of the Effective Date and ending on January 31, 2011 (the “Term”), except as the Term may be extended by mutual written agreement of the parties hereto or earlier terminated as hereafter provided. The period
during which the Consultant is performing services under this Agreement shall be referred to herein as the “Consulting Period.” 
 2. Consulting Services. During the Consulting Period, the Consultant shall perform consulting services for the Company. Such consulting services are anticipated to include, but not limited to,
working with Company management at a strategic level with respect to the Company’s commercialization planning, business and corporate development activities and investor relations. During the Term, the Consultant will devote 160 hours per month
to accomplishing his duties and responsibilities under this Agreement. Consultant shall make himself available in person for meetings and consultation with Company employees at the Company’s headquarters in St. Paul, Minnesota upon reasonable
request. Consultant’s principal contact at EnteroMedics shall be Mark B. Knudson, Ph.D., and Consultant shall accept instructions/directions from and report to this contact person or any other designee specified by Dr. Knudson. 

3. Independent Contractor. 
 (a) The Consultant shall perform the consulting services described in Section 2 as an independent contractor without the power to bind or represent the Company for any purpose whatsoever. Nothing
herein contained shall be construed to constitute the parties hereto as partners or as joint venturers, or either as agent of the other, or as employer and employee. The Consultant shall not present himself as an employee of the Company or any of
its affiliates. 

 (b) The Consultant shall not be entitled to participate in any employee benefit plans
maintained by on behalf of the Company or any of its affiliates during the Consulting Period. The Consultant hereby acknowledges his separate responsibility for all federal and state unemployment compensation taxes and business license fees, if
applicable. 
 4. Compensation. 
 (a) Consulting Fee. In remuneration for the consulting services to be performed under this Agreement by the Consultant during the Consulting Period, the Consultant shall receive a monthly
consulting fee equal to seven thousand dollars ($7,000.00) (the “Consulting Fee”), payable no less frequently than monthly in arrears. The Consulting Fee shall be in addition to, and not in lieu of, those fees or other remuneration to
which the Consultant may be entitled pursuant to Company policies in his position as member of the Board of Directors. 
 5.
Expenses. The Company will reimburse Consultant for actual incidental expenses (with no increase for handling or other mark-up) incurred in performing this Agreement, but such expenses shall not exceed one hundred dollars ($100) per month
without the Company’s prior written consent. Travel expenses must be approved in advance by the Company. Consultant shall provide the Company with appropriate documentation for tax purposes for all expenses paid by the Company. The Company will
reimburse Consultant for one-third the cost of Consultants administrative assistant expenses. Consultant shall submit monthly invoices for time and expenses. 
 6. Termination. During the Term, this Agreement and the Consulting Period may be terminated at any time by the Company or the Consultant, with or without cause, upon thirty (30) days’
prior written notice to the other party. The Agreement may be terminated by the Company immediately for any willful breach by Consultant of this Agreement or any willful misconduct or malfeasance by Consultant that may be detrimental or harmful to
the Company. In the event of the termination of this Agreement pursuant to this Section 6, the Company’s obligations under Section 4(a) shall cease on the effective date of such termination. In the event of the Consultant’s death
or permanent disability, the Agreement and Consulting Period shall terminate. The provisions of this Section 6, as well as Sections 7, 8, 9 and 15 shall survive the expiration or termination of this Agreement and shall remain in full force and
effect in accordance with the terms thereof. 
 7. Exclusivity. Due to the confidential nature of the information which
will be disclosed to Consultant in connection with his performance of the consulting services under this Agreement, Consultant shall not do any other consulting work for any other third party in the area of the Company’s products, services or
Technology or for any competitor or potential competitor of the Company during the Term and for a period of six months thereafter without prior approval by the Company. The Company’s “Technology” shall include the Company’s
proprietary VBLOCTM, vagal blocking therapy, and Maestro TM System or any similar device or related processes, products or 

 
services related to obesity management or treatment of gastrointestinal disorders, including, without limitation, the use of neuroblocking or neurostimulation to treat obesity, its associated
co-morbidities, metabolic syndrome and gastrointestinal disorders. 
 8. Confidential Information; Non-Solicitation. The
parties hereto recognize that a major need of the Company is to preserve its specialized knowledge, trade secrets, and confidential information. The strength and good will of the Company is derived from the specialized knowledge, trade secrets, and
confidential information generated from experience with the activities undertaken by the Company. The disclosure of this information and knowledge to competitors would be beneficial to them and detrimental to the Company. The Consultant acknowledges
that the proprietary information, observations and data obtained by him during the Consulting Period concerning the business or affairs of the Company are the property of the Company. By reason of being a member of the Company’s Board of
Directors and through the services provided under this Agreement, the Consultant has or will have access to, and has obtained or will obtain, specialized knowledge, trade secrets and confidential information about the Company’s operations.
Therefore, the Consultant hereby agrees as follows, recognizing that the Company is relying on these agreements in entering into this Agreement: 
 (a) The Consultant will not use, disclose to others, or publish or otherwise make available to any other party any inventions or any Confidential Information about the affairs of the Company, including
but not limited to confidential information concerning the results of the Company’s clinical trials and financial condition. “Confidential Information” shall include any information considered by the Company to be confidential and/or
proprietary that is disclosed by the Company to Consultant, all confidential information of third parties that is to be held as confidential by the Company, commercial or trade secrets about Company’s proprietary Technology, products, devices
and methods, as well as information about the Company’s engineering designs, plans and standards, commercial plans, sales and marketing plans, techniques and reports, analytical techniques, technical information, employee information, or
financial and business records, any of which contains proprietary information created or acquired by the Company and which information is held in confidence by Company. Confidential Information does not include information which: (i) becomes
generally available to the public, unless said Confidential Information was disclosed in violation of a confidentiality agreement; or (ii) becomes available to the Consultant on a non-confidential basis from a source other than the Company or
its agents, provided that such source is not bound by a confidentiality agreement with the Company or has not breached a duty of confidentiality to the Company in disclosing such information. 

(b) During the Term and for twelve (12) months thereafter, the Consultant will not directly or indirectly through another entity
(i) induce any employee of the Company to leave the Company’s employ (unless the Board of Directors shall have authorized such employment and the Company shall have consented thereto in writing) or in any way interfere with the
relationship between the Company and any employee thereof or (ii) tortuously interfere with the Company’s business relationship with any 

 
supplier, customer, vendor, clinical trial sponsor or other business relation of the Company. 
 9. Intellectual Property; Works of Authorship. 
 (a) Consultant agrees to
disclose promptly to the Company all inventions, improvements, know-how, formulas, trade secrets, secret processes, technical information, or any other intellectual property (other than works of authorship) made or conceived, either alone or jointly
with others, during the term of this Agreement and for six (6) months thereafter as a result of the services provided pursuant to this Agreement or of the Confidential Information obtained by Consultant during the term of this Agreement or any
extension thereof. Consultant agrees that the Company shall be the exclusive owner of the entire right, title, and interest in and to any and all such intellectual property, including any patent applications and any patents that may issue therefrom
anywhere in the world. Consultant agrees to assign all right, title, and interest in and to such intellectual property to the Company without further payment from the Company. Consultant also agrees that, upon the Company’s request and at the
Company’s expense, Consultant will provide reasonable assistance to the Company in prosecuting, maintaining, and protecting patents covering any such intellectual property. 

(b) Any original work of authorship including any written, pictorial, graphic or audiovisual work, sound recording, courseware design or
architecture in any form including, but not limited to, computer generated files and code, created by the Consultant in the course of providing services to the Company under this Agreement shall be deemed as “works made for hire” and be
the sole property of the Company and the Company shall own all the rights including the rights to copyright in the work. To the extent that any of the foregoing does not qualify as a “work made for hire,” Consultant hereby irrevocably
transfers, assigns and conveys the exclusive copyright ownership thereof to the Company, free and clear of any liens, claims or other encumbrances, to the fullest extent permitted by law. Consultant agrees to execute all documents and perform all
acts that the Company may reasonably request in order to assist the Company in perfecting its rights in and to the works developed under this Agreement anywhere in the world. The Company will reimburse Consultant for any expenses reasonably incurred
by Consultant in so doing. 
 (c) The obligations to assign inventions and copyrights to the Company shall not apply to any
invention or copyrights for which no equipment, supplies, facility or trade secret information of the Company was used and which was developed entirely on the Consultant’s own time, and (1) which does not relate (a) directly to the
business of the Company or (b) to the Company’s actual or demonstrably anticipated research or development, or (2) which does not result from any work performed by the Consultant for the Company. 

10. Entire Agreement. This Agreement sets forth the entire agreement and understanding of the parties hereto with respect to the
matters covered hereby and supersedes any prior agreement or understanding whether oral or written between the 

 
parties with respect to the matters covered hereby. Nothing in this Agreement shall be construed to grant Consultant any right of service on the Company’s Board of Directors or committee
thereof. 
 11. Notices. All notices required or permitted by this Agreement shall be in writing and may be delivered in
person, sent by certified or registered mail, return receipt required, postage paid to the addresses stated above or to such other address as either party may designate or by facsimile to such facsimile number as either party may designate. All
mailing notices shall be deemed effective upon depositing in the mail. 
 12. Waiver. The waiver of either party of a
breach of any provision of this Agreement shall not operate as or be construed as a continuing waiver or as a consent to or waiver of such subsequent breach. 
 13. Modification. This Agreement may only be modified in writing signed by both parties. 
 14. Nonassignable. Since the consulting services to be provided under this Agreement are personal, all duties to be performed by Consultant may not be assigned to any other individual or third
party without the written consent of the Company. 
 15. Governing Law. This Agreement shall be governed by and construed
in accordance with the internal laws of the State of Minnesota, without regard to its principles of conflicts of laws. ANY RIGHT TO TRIAL BY JURY WITH RESPECT TO ANY CLAIM, ACTION, SUIT OR PROCEEDING ARISING OUT OF THIS AGREEMENT OR ANY OF THE
MATTERS CONTEMPLATED HEREBY IS WAIVED BY THE COMPANY AND CONSULTANT. THE COMPANY AND CONSULTANT HEREBY SUBMIT TO THE EXCLUSIVE JURISDICTION OF THE FEDERAL AND STATE COURTS LOCATED IN HENNEPIN COUNTY, MINNESOTA, IN CONNECTION WITH ANY DISPUTE RELATED
TO THIS AGREEMENT OR ANY OF THE MATTERS CONTEMPLATED HEREBY. 
 16. Severability. If one or more provisions of this
Agreement are held to be unenforceable under applicable law, such provision shall be excluded from this Agreement and the balance of the Agreement shall be interpreted as if such provision were so excluded and shall be enforceable in accordance with
its terms. 
 17. Counterparts. This Agreement may be executed in one or more counterparts, each of which shall be deemed
to be an original and all of which together shall constitute one and the same instrument. 
 (remainder of page intentionally
left blank) 

 IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the day and year
first above written. 
  

			
		 	ENTEROMEDICS, INC.
		
	By:	 	 /s/    MARK B. KNUDSON,
PH.D.

	Name:	 	Mark B. Knudson, Ph.D.
	Title:	 	President and Chief Executive Officer
		
		 	CONSULTANT
		
		 	 /s/    NICHOLAS L. TETI,
JR.

		 	        Nicholas L. Teti, Jr.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00185-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00185-of-00352.parquet"}]]